Concepedia

Monique Dail

MD

35

Publications

2.3K

Citations

25

H-Index

2002

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AbbVie (United States)

University of California, San Francisco

University of Colorado Denver

University of Pennsylvania

Monique Dail is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2002–2024

35

Publications

35

An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor

Mitchell Koolpe, Monique Dail, Elena B. Pasquale · Journal of Biological Chemistry · 2002 · 206 citations · Full text

Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Naval Daver, Alexander E. Perl, Joseph Maly et al. · Journal of Clinical Oncology · 2022 · 179 citations · Full text

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat et al. · Journal of Clinical Oncology · 2021 · 156 citations · Full text

EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity

Mitchell Koolpe, Rosemary Burgess, Monique Dail et al. · Journal of Biological Chemistry · 2005 · 141 citations · Full text

Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine

Daniel A. Pollyea, Keith W. Pratz, Andrew H. Wei et al. · Clinical Cancer Research · 2022 · 137 citations · Full text

Rows per page

1–5 of 35